Trial Profile
CONFIRM - Confirmation of Superiority of Complete Remission Concept Versus Classical Healing Concept for Treatment of Patients With Erosive GERD [gastroesophageal reflux disease]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jun 2013
Price :
$35
*
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Acronyms CONFIRM
- Sponsors ALTANA Pharma
- 04 May 2012 Company added (Takeda Global Research and Development Center, Inc) as reported by ClinicalTrials.gov.
- 08 Apr 2012 Results published in Alimentary Pharmacology and Therapeutics.
- 07 Aug 2008 New trial record.